Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Dexamethasone"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Jones%2C+John+R%22&type=Person&filter%5B%5D=topic_facet%3A%22Dexamethasone%22
/vufind/Search/Results?lookfor=%22Jones%2C+John+R%22&type=Person&filter%5B%5D=topic_facet%3A%22Dexamethasone%22
Search /vufind/Search2/Results?lookfor=%22Jones%2C+John+R%22&type=Person&filter%5B%5D=topic_facet%3A%22Dexamethasone%22
PubPharm (6)
1
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages : results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial
enthalten in:
British journal of haematology
| 2023
von
Jenner, M.
|
Pawlyn, C.
|
Davies, F.
| +16
Wird geladen...
2
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial
enthalten in:
Haematologica
| 2021
von
Jackson, G.
|
Davies, F.
|
Pawlyn, C.
| +21
Wird geladen...
3
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma : results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial
enthalten in:
British journal of haematology
| 2021
von
Jackson, G.
|
Pawlyn, C.
|
Cairns, D.
| +21
Wird geladen...
4
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+) : Interim analysis of an open-label randomised controlled trial
enthalten in:
PLoS medicine
| 2021
von
Jackson, G.
|
Pawlyn, C.
|
Cairns, D.
| +21
Wird geladen...
5
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials
enthalten in:
Blood
| 2020
von
Craig, Z.
|
Cook, G.
|
Pawlyn, C.
| +13
CommentIn: Blood. 2020 Aug 27;136(9):1019-1021. - PMID 32853375
Wird geladen...
6
Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI) : a multicentre, open-label, randomised, phase 3 trial
enthalten in:
The Lancet. Haematology
| 2019
von
Jackson, G.
|
Davies, F.
|
Pawlyn, C.
| +20
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Dexamethasone
Medienart
6
Aufsätze
6
E-Artikel
6
E-Ressourcen
Zeitschriftentitel
2
British journal of haematology
1
Blood
1
Haematologica
1
PLoS medicine
1
The Lancet. Haematology
Alle anzeigen ...
weniger ...
Thema
6
7S5I7G3JQL
Dexamethasone
6
Journal Article
6
Randomized Controlled Trial
5
Clinical Trial, Phase III
5
F0P408N6V4
5
Lenalidomide
5
Multicenter Study
5
Research Support, Non-U.S. Gov't
4
8N3DW7272P
4
Cyclophosphamide
3
69G8BD63PP
3
Bortezomib
2
4Z8R6ORS6L
2
Immunologic Factors
2
Thalidomide
2
lenalidomide
2
myeloma
1
58IFB293JI
1
5J49Q6B70F
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5
2020-
1
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6
Englisch
Haven't found what you're looking for?
Wird geladen...